Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
METNET: A phase II trial of metformin in patients with well differentiated neuro...
Dr João Glasberg - Instituto do Câncer do Estado de São Paulo, São Paulo, Brazil
METNET: A phase II trial of metformin in patients with well differentiated neuroendocrine tumours ( Dr João Glasberg - Instituto do Câncer do Estado de São Paulo, São Paulo, Brazil )
31 Mar 2022
Real-world increase in biomarker testing in lung cancer
Dr Virginia Calvo de Juan - Hospital Universitario Puerta de Hierro-Majadahonda,...
Real-world increase in biomarker testing in lung cancer ( Dr Virginia Calvo de Juan - Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain )
30 Mar 2022
EGFR testing: Best practice for NSCLC patients with exon 20 insertions
Dr Antonio Passaro, Dr Umberto Malapelle and Dr Joshua Sabari
EGFR testing: Best practice for NSCLC patients with exon 20 insertions ( Dr Antonio Passaro, Dr Umberto Malapelle and Dr Joshua Sabari )
30 Mar 2022
ASCO GU 2022: Latest in mHSPC
Prof Eleni Efstathiou, Prof Karim Fizazi, Prof Kim Chi and Prof Matthew Smith
ASCO GU 2022: Latest in mHSPC ( Prof Eleni Efstathiou, Prof Karim Fizazi, Prof Kim Chi and Prof Matthew Smith )
8 Mar 2022
Minimal residual disease in multiple myeloma
Prof Ola Landgren - University of Miami, Miami, USA
Minimal residual disease in multiple myeloma ( Prof Ola Landgren - University of Miami, Miami, USA )
8 Mar 2022
ASCO GU 2022: PARP inhibitors in prostate and MAGNITUDE
Dr Neal Shore and Prof Kim Chi
ASCO GU 2022: PARP inhibitors in prostate and MAGNITUDE ( Dr Neal Shore and Prof Kim Chi )
4 Mar 2022
An AI-derived digital pathology-based biomarker to predict the benefit of ADT in...
Prof Daniel Spratt - University Hospitals Seidman Cancer Center, Cleveland, USA
An AI-derived digital pathology-based biomarker to predict the benefit of ADT in PC with validation in NRG/RTOG 9408 ( Prof Daniel Spratt - University Hospitals Seidman Cancer Center, Cleveland, USA )
3 Mar 2022
Survival outcomes of unilateral RB based on pathological risk stratification-exp...
Dr Palwasha Rehman - Shaukat Khanum Memorial Cancer Hospital and Research Centre...
Survival outcomes of unilateral RB based on pathological risk stratification-experience at a tertiary care centre in Pakistan ( Dr Palwasha Rehman - Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan )
1 Mar 2022
NMIBC treated with IL-15RαFc superagonist N-803 and BCG infusion
Prof Sam Chang - Vanderbilt University School of Medicine, Nashville, USA
NMIBC treated with IL-15RαFc superagonist N-803 and BCG infusion ( Prof Sam Chang - Vanderbilt University School of Medicine, Nashville, USA )
28 Feb 2022
Latest developments in mHSPC
Prof Kurt Miller and Prof Laura-Maria Krabbe
Latest developments in mHSPC ( Prof Kurt Miller and Prof Laura-Maria Krabbe )
25 Feb 2022
ASCO GU 2022: The latest in CRPC, including PARP combo data
Prof Eleni Efstathiou, Prof Gerhardt Attard, Prof Noel Clarke and Prof Axel Mers...
ASCO GU 2022: The latest in CRPC, including PARP combo data ( Prof Eleni Efstathiou, Prof Gerhardt Attard, Prof Noel Clarke and Prof Axel Merseburger )
25 Feb 2022
Atezolizumab with or without radiotherapy for advanced squamous cell carcinoma o...
Dr Hielke Martijn de Vries - Netherlands Cancer Institute, Amsterdam, The Nether...
Atezolizumab with or without radiotherapy for advanced squamous cell carcinoma of the penis ( Dr Hielke Martijn de Vries - Netherlands Cancer Institute, Amsterdam, The Netherlands )
24 Feb 2022